Skip to content

LAURACEA

Active
Private limited companyfounded 20224 yrs activeLijsterbessendreef 18, 8020 Oostkamp, BelgiumKBO/BCE: BE 0790.770.526
Summary

LAURACEA has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €522,664 and a net result of €230,914. Equity is growing by ~77.9% per year across the filed fiscal years. Its solvency ranks better than 90% of 19918 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45,000 at 30 days acceptable
Liquidity ample (current ratio 15.53 against 4.73 in 2023; short-term debt: 5.7% and cash: 10.3% of total assets), and 5.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 4 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
94.3%
Return on assets
41.7%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 03-07-2025, 28 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
not confirmed
2024
28 d early
2023
16 d early
2022
12 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 19 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

LAURACEA was incorporated on 14 September 2022 as a Private limited company.1 Total assets rose from EUR 86,070 in 2022 to EUR 554,391 in 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2022 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€522,664▲ 79.1%
2023 · €291,750
Total assets
€554,391▲ 49.8%
2023 · €370,135
Net result
€230,914▲ 3.1%
2023 · €223,920
Working capital
€460,868▲ 57.9%
2023 · €291,803
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line202220232024
Operating result€83,820-€293,460▲ 250%€295,243▲ 0.6%
Net result€66,831within the sector's middle half-€223,920above the sector's middle half▲ 235%€230,914above the sector's middle half▲ 3.1%
Equity€67,831within the sector's middle half-€291,750within the sector's middle half▲ 330%€522,664above the sector's middle half▲ 79.1%
Total assets€86,070below the sector's middle half-€370,135within the sector's middle half▲ 330%€554,391within the sector's middle half▲ 49.8%
Debt€18,239-€78,385▲ 330%€31,726▼ 59.5%
Working capital€68,662-€291,803▲ 325%€460,868▲ 57.9%
Solvency78.8%within the sector's middle half-78.8%within the sector's middle half=94.3%above the sector's middle half▲ 15.5pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000€300,000Operating result 2022: €83,820€83,820Net result 2022: €66,831€66,831Operating result 2023: €293,460€293,460Net result 2023: €223,920€223,920Operating result 2024: €295,243€295,243Net result 2024: €230,914€230,914202220232024€0€100,000€200,000€300,000Operating result 2022: €83,820€83,800Net result 2022: €66,831€66,800Operating result 2023: €293,460€293,000Net result 2023: €223,920€224,000Operating result 2024: €295,243€295,000Net result 2024: €230,914€231,000202220232024
The operating result has risen two years in a row; 2024 is 1% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €554,391
Fixed assets €61,796
Current assets €492,595
Equity and liabilities €554,391
Equity €522,664 ▲ 79.1%
Debt €31,726 ▼ 59.5%
Debt's share of the balance-sheet total falls from 21.2% to 5.7%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€297,927▲
2023 · €293,460
Cash flow
€233,597▲
2023 · €223,920
Current ratio
15.53▲
2023 · 4.73
Debt to equity
0.06▼
2023 · 0.27
ROE
44.2%▼
2023 · 76.8%
ROA
41.7%▼
2023 · 60.5%
Interest coverage
2206.86▲
2023 · -3224.84
Debt ≤ 1 year
€31,726▼
2023 · €78,332
Income taxes
€72,313▲
2023 · €69,781
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,126 companies that looked in July 2024 the way this one looks now, 0.8% went bankrupt within 24 months and 97% are still going.

  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.8% went bankrupt
1.9% stopped otherwise
97% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,126 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 40 lines
Balance sheet Code20232024
Assets
Total assets20/58€370,135€554,391▲
Fixed assets21/28-€61,796
Tangible fixed assets22/27-€61,796
Furniture and vehicles24-€61,796
Current assets29/58€370,135€492,595▲
Amounts receivable within one year40/41€140,396€157,525▲
Trade receivables40€140,264€154,611▲
Other amounts receivable41€133€2,914▲
Current investments50/53-€275,000
Cash at bank and in hand54/58€228,687€57,378▼
Deferred charges and accrued income490/1€1,051€2,692▲
Equity and liabilities
Total equity and liabilities10/49€370,135€554,391▲
Equity10/15€291,750€522,664▲
Contributions10/11€1,000€1,000=
Reserves13€290,750€521,664▲
Distributable reserves133€290,750€521,664▲
Amounts payable17/49€78,385€31,726▼
Amounts payable within one year42/48€78,332€31,726▼
Trade debts44€1,573€2,458▲
Suppliers440/4€1,573€2,458▲
Taxes, remuneration and social security45€75,764€25,943▼
Taxes450/3€72,152€22,410▼
Remuneration and social security454/9€3,612€3,533▼
Other amounts payable47/48€994€3,326▲
Accrued charges and deferred income492/3€53€0▼
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0€2,683▲
Other operating charges640/8€115€219▲
Gross operating margin9900€293,575€298,145▲
Operating profit (loss)9901€293,460€295,243▲
Financial income75/76B€150€8,119▲
Recurring financial income75€150€8,119▲
Financial charges65/66B-€91€135▲
Recurring financial charges65-€91€135▲
Profit (loss) for the period before taxes9903€293,701€303,227▲
Income taxes67/77€69,781€72,313▲
Profit (loss) for the period9904€223,920€230,914▲
Profit (loss) for the period to be appropriated9905€223,920€230,914▲
Appropriation of the result
Profit (loss) to be appropriated9906€223,920€230,914▲
Transfer to equity691/2€223,920€230,914▲
To other reserves6921€223,920€230,914▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202220232024Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,998€0€2,683-
Other operating charges640/8-€115€219▲ 90.1%
Gross operating margin9900€86,819€293,575€298,145▲ 1.6%
Operating profit (loss)9901€83,820€293,460€295,243▲ 0.6%
Financial income75/76B-€150€8,119▲ 5,313%
Recurring financial income75-€150€8,119▲ 5,313%
Financial charges65/66B€25-€91€135▲ 248%
Recurring financial charges65€25-€91€135▲ 248%
Profit (loss) for the period before taxes9903€83,795€293,701€303,227▲ 3.2%
Income taxes67/77€16,965€69,781€72,313▲ 3.6%
Profit (loss) for the period9904€66,831€223,920€230,914▲ 3.1%
Profit (loss) for the period to be appropriated9905€66,831€223,920€230,914▲ 3.1%
Line202220232024Change
Assets
Total assets20/58€86,070€370,135€554,391▲ 49.8%
Fixed assets21/28--€61,796-
Tangible fixed assets22/27--€61,796-
Furniture and vehicles24--€61,796-
Current assets29/58€86,070€370,135€492,595▲ 33.1%
Amounts receivable within one year40/41€42,292€140,396€157,525▲ 12.2%
Trade receivables40€42,264€140,264€154,611▲ 10.2%
Other amounts receivable41€28€133€2,914▲ 2,099%
Current investments50/53--€275,000-
Cash at bank and in hand54/58€43,718€228,687€57,378▼ 74.9%
Deferred charges and accrued income490/1€60€1,051€2,692▲ 156%
Equity and liabilities
Total equity and liabilities10/49€86,070€370,135€554,391▲ 49.8%
Equity10/15€67,831€291,750€522,664▲ 79.1%
Contributions10/11€1,000€1,000€1,000=
Reserves13€66,831€290,750€521,664▲ 79.4%
Distributable reserves133€66,831€290,750€521,664▲ 79.4%
Amounts payable17/49€18,239€78,385€31,726▼ 59.5%
Amounts payable within one year42/48€17,408€78,332€31,726▼ 59.5%
Trade debts44€189€1,573€2,458▲ 56.2%
Suppliers440/4€189€1,573€2,458▲ 56.2%
Taxes, remuneration and social security45€16,965€75,764€25,943▼ 65.8%
Taxes450/3€16,965€72,152€22,410▼ 68.9%
Remuneration and social security454/9-€3,612€3,533▼ 2.2%
Other amounts payable47/48€254€994€3,326▲ 234%
Accrued charges and deferred income492/3€831€53€0▼ 100%
Line202220232024Change
Profit (loss) for the period9904€66,831€223,920€230,914▲ 3.1%
+ Depreciation and write-downs630€2,998€0€2,683-
Operating cash flow (approximation)€69,829€223,920€233,597▲ 4.3%
Change in cash-€184,969-€171,309▼ 193%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
03-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2022net €230,914 ▲3.1%
Operating result €295,243, net result €230,914, both a record.
31-12
Financial Liquidity triplescurrent ratio 15.53
Current ratio from 4.73 to 15.53; short-term debt falls from €78,332 to €31,726.
31-12
Financial Equity above €500,000Eq €522,664 ▲79.1%
3 profitable years in a row build equity to €522,664.
15-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Equity above €200,000Eq €291,750 ▲330%
2 profitable years in a row build equity to €291,750.
19-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oostkamp · 1 establishment unit since 2022
seat establishment The establishment unit on the map
Ground area
6,492 m²
Building footprint
374 m²
Volume, LiDAR
1,944 m³
Parcel 31037B0081/00V000, Flanders · tallest building 8.5 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
LAURACEA
Lijsterbessendreef 18, 8020 OostkampSpecialist medical practice
since 20222.335.438.712
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31037B0081/00V000 Flanders 6,492 m² 1 · 374 m² 8.5 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 6,408 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded14-09-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0790770526
Also 9925:BE0790770526
Registered 28-05-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.